TRT(600085)2024-08-09 08:44Group 1: Business Operations and Marketing Strategies - The company has implemented marketing reforms to enhance operational quality, focusing on large product strategies and premium strategies to create precise marketing "explosion points" [1] - The company has selected over 50 key potential products for resource allocation in production, supply, research, and marketing [2] - The overall business operations are stable, and the marketing reforms have met expectations [1] Group 2: Product Development and Quality Management - The company is committed to modernizing traditional Chinese medicine and has several new product development projects each year [3] - The company conducts secondary development on existing products to improve market share and sales volume [3] - Quality management systems are being strengthened to ensure high product standards and effective quality control [3] Group 3: Market Challenges and Responses - Rising costs of medicinal materials due to environmental factors and regulations are being addressed through procurement reforms and partnerships with large planting bases [4] - The company is exploring the impact of imported natural products on cost pressures, but the effectiveness of such policies remains uncertain [4] - The company is closely monitoring the fluctuations in medicinal material prices to optimize procurement strategies [4] Group 4: Internationalization and Market Expansion - The company is enhancing its international presence by adapting marketing strategies to local cultures and shopping habits [5] - Efforts are being made to transform overseas stores into experiential service centers, particularly in key markets like Hong Kong and Macau [5] - The company aims to accelerate the internationalization of traditional Chinese medicine, leveraging global market opportunities [5]